These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis. Venci JV; Gandhi MA Ann Pharmacother; 2013 Dec; 47(12):1697-702. PubMed ID: 24259625 [TBL] [Abstract][Full Text] [Related]
3. Response to comment on "Dimethyl fumarate (tecfidera): a new oral agent for multiple sclerosis". Venci J; Gandhi MA Ann Pharmacother; 2014 Nov; 48(11):1537. PubMed ID: 25301830 [No Abstract] [Full Text] [Related]
4. Dimethyl fumarate (Tecfidera) for multiple sclerosis. Med Lett Drugs Ther; 2013 Jun; 55(1418):45-7. PubMed ID: 24662841 [No Abstract] [Full Text] [Related]
5. Lorcaserin, dimethyl fumarate, and bedaquiline fumarate. Hussar DA; Polyak G J Am Pharm Assoc (2003); 2013; 53(3):328-30, 332, 334. PubMed ID: 23699683 [No Abstract] [Full Text] [Related]
7. Dimethyl fumarate for treating relapsing multiple sclerosis. Sheremata W; Brown AD; Rammohan KW Expert Opin Drug Saf; 2015 Jan; 14(1):161-70. PubMed ID: 25382392 [TBL] [Abstract][Full Text] [Related]
8. Tecfidera(®): an approach for repurposing. Spencer RP Pharm Pat Anal; 2014 Mar; 3(2):183-98. PubMed ID: 24588595 [TBL] [Abstract][Full Text] [Related]
9. Second oral MS drug wins FDA nod. Sheridan C Nat Biotechnol; 2013 May; 31(5):373. PubMed ID: 23657376 [No Abstract] [Full Text] [Related]
10. The best clinical paper on multiple sclerosis in 2012. Miller AE Mult Scler; 2013 Apr; 19(5):520-1. PubMed ID: 23599182 [No Abstract] [Full Text] [Related]
11. Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects. Linker RA; Gold R Curr Neurol Neurosci Rep; 2013 Nov; 13(11):394. PubMed ID: 24061646 [TBL] [Abstract][Full Text] [Related]
12. Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate. Ratchford EV; Baldanza JT; Pardo CA J Neurol; 2014 Apr; 261(4):831-2. PubMed ID: 24603974 [No Abstract] [Full Text] [Related]
13. Dimethyl fumarate for multiple sclerosis. Papadopoulou A; D'Souza M; Kappos L; Yaldizli O Expert Opin Investig Drugs; 2010 Dec; 19(12):1603-12. PubMed ID: 21067468 [TBL] [Abstract][Full Text] [Related]
14. [Immunomodulation with oral dosage forms and their mechanisms of action]. Gold R Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S9. PubMed ID: 24242042 [No Abstract] [Full Text] [Related]
15. The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis. Fox R Can J Neurosci Nurs; 2012; 34(3):7-11. PubMed ID: 23362583 [No Abstract] [Full Text] [Related]
16. Dimethyl fumarate - only an anti-psoriatic medication? Meissner M; Valesky EM; Kippenberger S; Kaufmann R J Dtsch Dermatol Ges; 2012 Nov; 10(11):793-801. PubMed ID: 22897153 [TBL] [Abstract][Full Text] [Related]
17. [Multiple sclerosis: new treatment options]. Marziniak M MMW Fortschr Med; 2014 Mar; 156 Spec No 1(1):69-73; quiz 74. PubMed ID: 24930351 [No Abstract] [Full Text] [Related]
18. Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS. Methner A; Zipp F Nat Rev Neurol; 2013 Feb; 9(2):72-3. PubMed ID: 23338282 [TBL] [Abstract][Full Text] [Related]
19. Drug evaluation: BG-12, an immunomodulatory dimethylfumarate. Wakkee M; Thio HB Curr Opin Investig Drugs; 2007 Nov; 8(11):955-62. PubMed ID: 17979030 [TBL] [Abstract][Full Text] [Related]